Hyperdiploidy: the longest, most widely prevalent, and most mysterious form of acute lymphoblastic leukemia in children

Published On: 29 Oct, 2022 12:36 PM | Updated On: 21 May, 2024 3:54 AM

Hyperdiploidy: the longest, most widely prevalent, and most mysterious form of acute lymphoblastic leukemia in children

Hyperdiploidy represents the largest genetic entity of B-cell precursor acute lymphoblastic leukemia in children. A recent study discussed in detail the diagnostic hallmark of its two variants, a chromosome count between 52 and 67, respectively. 

The classical HD form includes heterozygous di-, tri-, and tetrasomies, whereas the nonclassical one (usually viewed as "duplicated hyperhaploid") contains only disomies and tetrasomies. Although they show apparently different clinical behavior, these two sub-forms can, in principle, be produced by the same chromosomal maldistribution mechanism. Moreover, their respective array, gene expression, and mutation patterns also point toward their biological similarity. 

Even though in-depth analyses of the genomic intricacies of classical HD leukemia are indispensable for elucidating the disease process, the subsequent results have surprisingly little impact on treatment stratification. This can be attributed to the patient's overall good prognoses, low relapse rates, and excellent treatment outcomes. However, despite this underutilization, detailed genetic characterization of HD leukemias may be crucial, particularly in planned treatment reduction trials, to further stratify treatment, manage patients, and analyze clinical outcomes. It should thus become an integral part of all upcoming treatment studies.

Leukemia. 2022 Oct 20. doi: 10.1038/s41375-022-01720-z. Epub ahead of print. PMID: 36266323.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks